Dr. Rustin A. Massoudi, MD

Dr. Massoudi practices at Southern California Permanente Medical Group in Anaheim, California.

Dr. Massoudi's NPI, 1861836843, was assigned on April 22, 2013. Dr. Massoudi graduated from UC San Diego School of Medicine in 2013. Dr. Massoudi holds California license A131914.

Dr. Massoudi's primary practice is Southern California Permanente Medical Group, at 441 N Lakeview Ave, Anaheim, CA 92807 in Orange County. The practice phone is (714) 279-4000.

Dr. Massoudi's primary practice is Southern California Permanente Medical Group in Anaheim, California. Dr. Massoudi is also affiliated with Orange County - Anaheim Medical Center. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Massoudi to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Massoudi practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Massoudi's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Massoudi is board certified in urology by the American Board of Urology. Dr. Massoudi is licensed in California.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery and kidney stone disease among the conditions Dr. Massoudi treats.

CMS data shows 1,050 Medicare services from Dr. Massoudi across 18 procedure codes in 2024, for 550 Medicare patients. Medicare paid $129,088 for them.

CMS counts 550 Medicare patients who saw Dr. Massoudi in 2024. The largest group is 65 to 74, with 238 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Massoudi's median patient age at 71, with 19% women.

In 2024, Dr. Massoudi wrote 1,051 Medicare Part D claims for 331 patients. 93% of them were for generic drugs. CMS names the drug for 937 of them, across 13 drugs with 11 or more claims each, at $68,203 in total drug cost. In 2023, CMS named 1,013 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Massoudi for performance year 2024, reported as part of a group. Dr. Massoudi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Massoudi, published from 2011 to 2018. 2011 was the busiest year, with 2. The most frequent topics are Kidney Diseases, Cystic and Kidney Neoplasms. Dr. Massoudi's most frequent co-authors are John Thomas Leppert, MD, Joseph Gerard Gleeson, MD and Tin Chan Ngo, MD.

CMS Open Payments shows 69 general payments to Dr. Massoudi from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Boston Scientific Corporation paid the most, $3,105.

Dmand AI lists 4 awards for Dr. Massoudi, most recently Stanford TriValley Clinical Academy Teaching Award in 2024.

Dr. Massoudi graduated from UC San Diego School of Medicine in 2013. Dr. Massoudi is a member of AMA and AUA.

Dr. Massoudi is in network with 7 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.